Decoy Therapeutics Partners with Quantori to Develop Cloud-Native Peptide Design Platform
Decoy Therapeutics (DCOY) announced a collaboration with Quantori, a provider of digital transformation services and technology for the life sciences and healthcare industries, supported by funding from Google Cloud (GOOG, GOOGL), to build a Google Cloud-native peptide design platform intended to dramatically increase the speed and scale of antiviral peptide discovery. The collaboration will deliver a production-grade, cloud-based infrastructure built on Google Cloud Platform that integrates advanced protein folding models, molecular dynamics simulations and performance optimization tools into a single scalable environment. The new platform is designed to integrate Cloud-native infrastructure, advanced machine learning and high-performance computing directly into Decoy's proprietary IMP ACT design-build-test-learn engine. By unifying these capabilities into a single production-grade computational environment, Decoy expects to increase computational throughput by approximately 25- to 100-fold, enabling a step-change improvement in how rapidly new peptide candidates can be conceived, optimized and advanced. Additionally, the modularity of the platform will allow Decoy to continually adapt and upgrade its capabilities in the fluid competitive space of AI-driven molecular design. The architecture also lays the foundation for a new generation of AI-enabled research tools that can integrate emerging protein design models, generative AI techniques, and experimental data streams into Decoy's discovery workflows.
